<DOC>
	<DOCNO>NCT00854438</DOCNO>
	<brief_summary>Thesis : Is drug-induced anticholinergic activity additive result total anticholinergic load cause harmful side effect old , fragile patient ? Is possible reduce anticholinergic load multidisciplinary medical review include pharmacist physician ? The effect medical review measure cognitive test ( MMS CERADS word list ) , measure mouth dryness , serum level anticholinergic activity , activity daily live neuropsychiatric symptom . Design : A randomized , control , single blind interventional study Norwegian nursing home .</brief_summary>
	<brief_title>Reduction Adverse Events Anticholinergic Drugs Multidisciplinary Medical Reviews Norwegian Nursing Homes</brief_title>
	<detailed_description>Several study claim drug show anticholinergic activity vitro cause high level serum anticholinergic activity vivo might cause impaired cognitive functional function elderly . Pathophysiological change Alzheimer ` dementia make patient particularly vulnerable anticholinergic cognitive impairment . The PRADA-study first interventional study evaluate clinical effect reduce drug-induced anticholinergic load patient dementia . This also first interventional study Nordic country evaluate clinical effect clinical pharmacy .</detailed_description>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>Longterm nursing home patient none , mild moderate dementia ( evaluated CDR9 , use drug total anticholinergic burden might lead adverse event . Not able perform testes physical psychiatric illness .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>anticholinergic drug</keyword>
	<keyword>adverse event</keyword>
	<keyword>elderly</keyword>
	<keyword>clinical pharmacist</keyword>
	<keyword>Evaluate clinical effect reduce anticholinergic elderly</keyword>
</DOC>